Advertisement

  • No markup for post-processing
  • No markup for post-processing

eFT508, a Potent and Selective Mitogen-Activated Protein Kinase Interacting Kinase (MNK) 1 and 2 Inhibitor, Is Efficacious in Preclinical Models of Diffuse Large B-Cell Lymphoma (DLBCL)

Kevin R. Webster, Vikas K Goel, Ivy NJ Hung, Gregory S Parker, Jocelyn Staunton, Melissa Neal, Jolene Molter, Gary G Chiang, Katti A. Jessen, Christopher J Wegerski, Samuel Sperry, Vera Huang, Joan Chen, Peggy A Thompson, James R Appleman, Stephen E Webber, Paul A Sprengeler, Siegfried H Reich